Totus Medicines is applying revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $106M
Investors 3
| Date | Name | Website |
| 17.02.2022 | DCVC | dcvc.com/ |
| 02.09.2020 | Social Imp... | social-imp... |
| - | DHVC | dh.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.12.2023 | Series B | $66M | - |
| 09.12.2021 | Series A | $40M | - |
Mentions in press and media 8
| Date | Title | Description |
| 03.04.2024 | From generative chemistry to computational astrophysics, startups employ new methods to fight cancer | Here are a few startups in the cancer space that made headlines recently The recent revelation of Princess Kate Middleton’s battle with cancer has sent ripples across the globe, reminding us that this disease knows no boundaries of status o... |
| 17.12.2023 | Totus Medicines Closes $66M Series B Funding | Totus Medicines, an Emeryville, CA-based small molecule drug discovery and development company using covalent libraries and AI tools, closed a $66M Series B financing. The round was led by DCVC Bio with participation from North Pond Venture... |
| 16.12.2023 | USA-based Totus Medicines raises USD 66 million in Series B | California, USA-based company revolutionizing small molecule drug discovery and development using covalent libraries and AI tools, Totus Medicines, raised USD 62 million in Series B funding. The round took place on December 15, 2023. DCVC B... |
| 15.12.2023 | Totus Medicines Bags $66M Series B Funding | EMERYVILLE, CA, Totus Medicines, a company revolutionizing small molecule drug discovery and development, announced it has closed a $66M Series B financing led by DCVC Bio. >> Click here for more funding data on Totus Medicines &g... |
| 10.12.2021 | SEC Chair Gary Gensler finally laid out what he has against SPACs | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. I know, I know. We were just talking about SPACs earlier this week. But this is big. Gary Gensler... |
| 10.12.2021 | SEC Chair Gary Gensler finally laid out what he has against SPACs | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. I know, I know. We were just talking about SPACs earlier this week. But this is big. Paid Content... |
| 09.12.2021 | Totus tots up $40M in series A funding to go after competitive cancer space | Totus Medicines is making a play for the PI3Kα inhibitor market. Exiting stealth with a $40 million series A round, the Massachusetts-based biotech plans to advance a molecule designed to improve on existing PI3Kα inhibitors such as Novarti... |
| - | Biotech startup with AlphaGo-type AI approach snags $30M | In the world of artificial intelligence and machine learning, Google Deepmind’s AlphaGo program defeating world champion Lee Sedol at the game Go on March 19, 2016, was a watershed moment. It showed, among other things, that if an AI algori... |